From: Sex-differences in the management and clinical outcome among patients with acute coronary syndrome
Variables | Men (n = 422) | Women (n = 264) | P-value |
---|---|---|---|
Emergency department | |||
Aspirin loading, n (%) | 326 (77.3) | 191 (72.3) | 0.18 |
Clopidogrel loading, n (%) | 187 (44.3) | 127 (48.1) | 0.69 |
Ticagrelor loading, n (%) | 106 (25.1) | 48 (18.2) | 0.03 |
Nitroglycerin IV, n (%) | 126 (29.9) | 72 (27.3) | 0.24 |
Morphine IV, n (%) | 30 (7.1) | 25 (9.5) | 0.11 |
Duration since arrived at ED to first ECG test (min)* | 5.7 (3.1–10.2) | 7.5 (4.7–12.5) | 0.006 |
Duration since arrival at ED to first Hs-cTNT test (min)* | 7.0 (4.9–13.5) | 9.1 (5.6–15.3) | 0.01 |
Duration since arrival at ED to Cardiologist consultation (min)* | 15.3 (8.5–19.1) | 17.8 (9.6–20.7) | 0.03 |
Inpatient department | |||
Aspirin, n (%) | 422 (100) | 264 (100) | 0.99 |
Clopidogrel, n (%) | 367 (87.0) | 225 (85.2) | 0.86 |
Ticagrelor, n (%) | 50 (11.8) | 25 (9.5) | 0.59 |
Statins, n (%) | 412 (97.6) | 253 (95.8) | 0.72 |
Betablocker, n (%) | 336 (79.6) | 205 (77.7) | 0.48 |
RASi, n (%) | 252 (59.7) | 138 (52.3) | 0.08 |
PPI, n (%) | 129 (30.6) | 79 (29.9) | 0.70 |
Antidiabetic, n (%) | 113 (26.8) | 73 (27.7) | 0.83 |
Anticoagulant, n (%) | 25 (5.9) | 17 (6.4) | 0.64 |
Oxygen supplement, n (%) | 73 (17.3) | 58 (22.0) | 0.06 |